IL17A and Alzheimer disease: We showed that expression levels of cytokines, such as IL-5, IL-17, CCL5, MIP-1ß (CCL4), and MIP-2, were increased by DNCB and downregulated by AdMSCs, but not by HDFs, in a mouse model of AD.